Compounds > ciladopa
Page last updated: 2024-09-04

ciladopa and mesulergine

ciladopa has been researched along with mesulergine in 1 studies

Compound Research Comparison

Studies
(ciladopa)		Trials
(ciladopa)		Recent Studies (post-2010)
(ciladopa)		Studies
(mesulergine)		Trials
(mesulergine)		Recent Studies (post-2010) (mesulergine)
11302651028

Protein Interaction Comparison

ProteinTaxonomyciladopa (IC50)mesulergine (IC50)
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0019
5-hydroxytryptamine receptor 7Homo sapiens (human)0.205
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.0021
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0052
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.0021

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lang, AE1

Reviews

1 review(s) available for ciladopa and mesulergine

ArticleYear
Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine".
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:3 Suppl

    Topics: Antiparkinson Agents; Bromocriptine; Dopamine; Ergolines; Humans; Parkinson Disease; Piperazines

1987